QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:HYPR

Hyperfine - HYPR Stock Forecast, Price & News

$1.25
-0.02 (-1.58%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.23
$1.30
50-Day Range
$0.85
$1.88
52-Week Range
$0.68
$4.10
Volume
90,515 shs
Average Volume
1.48 million shs
Market Capitalization
$87.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.97

Hyperfine MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
218.6% Upside
$3.97 Price Target
Short Interest
Bearish
5.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.81mentions of Hyperfine in the last 14 days
Based on 19 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars

Medical Sector

686th out of 995 stocks

Electromedical Equipment Industry

14th out of 24 stocks


HYPR stock logo

About Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings. Hyperfine, Inc. was incorporated in 2014 and is based in Guilford, Connecticut.

Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Stock News Headlines

Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Hyperfine (HYPR) Gets a Buy from B.Riley Financial
Banking Nightmare
During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …
Hyperfine's Earnings: A Preview
Hyperfine (HYPR) to Release Quarterly Earnings on Tuesday
187K Reasons To Be Bullish On Hyperfine Stock
Hyperfine, Inc. (HYPR) Q3 2022 Earnings Call Transcript
Hyperfine Reports Third Quarter 2022 Financial Results
See More Headlines
Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Company Calendar

Today
3/27/2023
Next Earnings (Estimated)
5/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HYPR
Fax
N/A
Employees
186
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.97
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$2.40
Forecasted Upside/Downside
+218.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-64,850,000.00
Net Margins
-1,073.73%
Pretax Margin
-1,073.73%

Debt

Sales & Book Value

Annual Sales
$6.81 million
Book Value
$2.65 per share

Miscellaneous

Free Float
52,149,000
Market Cap
$87.87 million
Optionable
Not Optionable
Beta
0.32

Key Executives

  • Mr. R. Scott Huennekens CPA (Age 58)
    M.B.A., Exec. Chairman
    Comp: $83.04k
  • Ms. Maria Sainz (Age 56)
    CEO, Pres & Director
    Comp: $1.78k
  • Dr. Jonathan M. Rothberg Ph.D. (Age 58)
    Founder & Vice Chairman
    Comp: $1.37k
  • Mr. Mark A. Hughes (Age 59)
    VP of Hardware Engineering & Operations
    Comp: $366.67k
  • Dr. Khan M. Siddiqui M.D. (Age 49)
    Chief Medical Officer & Chief Strategy Officer
    Comp: $475.25k
  • Mr. Alok Gupta (Age 56)
    Chief Financial Officer
  • Ms. Kyla Pavlina J.D.
    Chief People Officer
  • Mr. Scott A. White (Age 48)
    Chief Commercial Officer
  • Mr. Tom Teisseyre
    Chief Product Officer













HYPR Stock - Frequently Asked Questions

Should I buy or sell Hyperfine stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HYPR shares.
View HYPR analyst ratings
or view top-rated stocks.

What is Hyperfine's stock price forecast for 2023?

3 brokerages have issued 1-year target prices for Hyperfine's shares. Their HYPR share price forecasts range from $2.40 to $7.00. On average, they expect the company's share price to reach $3.97 in the next year. This suggests a possible upside of 218.6% from the stock's current price.
View analysts price targets for HYPR
or view top-rated stocks among Wall Street analysts.

How have HYPR shares performed in 2023?

Hyperfine's stock was trading at $0.84 at the start of the year. Since then, HYPR stock has increased by 48.2% and is now trading at $1.2450.
View the best growth stocks for 2023 here
.

When is Hyperfine's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our HYPR earnings forecast
.

What guidance has Hyperfine issued on next quarter's earnings?

Hyperfine issued an update on its FY 2023 earnings guidance on Wednesday, March, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $10.00 million-$14.00 million, compared to the consensus revenue estimate of $14.65 million.

What is Hyperfine's stock symbol?

Hyperfine trades on the NASDAQ under the ticker symbol "HYPR."

Who are Hyperfine's major shareholders?

Hyperfine's stock is owned by many different institutional and retail investors. Top institutional investors include HealthCor Management L.P. (5.50%), Security Benefit Life Insurance Co. KS (3.49%), Wells Fargo & Company MN (0.54%), Jefferies Financial Group Inc. (0.43%), Caz Investments LP (0.07%) and Susquehanna International Group LLP (0.04%). Insiders that own company stock include Alok Gupta, Hc Sponsor Llc, Jonathan M Rothberg, Khan Siddiqui, Maria Sainz and Neela Paykel.
View institutional ownership trends
.

How do I buy shares of Hyperfine?

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hyperfine's stock price today?

One share of HYPR stock can currently be purchased for approximately $1.25.

How much money does Hyperfine make?

Hyperfine (NASDAQ:HYPR) has a market capitalization of $87.87 million and generates $6.81 million in revenue each year. The company earns $-64,850,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis.

How many employees does Hyperfine have?

The company employs 186 workers across the globe.

How can I contact Hyperfine?

Hyperfine's mailing address is 55 HUDSON YARDS 28TH FLOOR, NEW YORK NY, 10001. The official website for the company is hyperfine.io. The company can be reached via phone at 866-796-6767 or via email at investors@hyperfine.io.

This page (NASDAQ:HYPR) was last updated on 3/27/2023 by MarketBeat.com Staff